Sort   by:  
 Page size 
UnknownUS Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816.

Purpose

Four US National Clinical Trials Network components (Southwest Oncology Group, Cancer and Leukemia Group B/Alliance, Eastern Cooperative Oncology Group, and the AIDS Malignancy Consortium) conducted a phase II Intergroup clinical trial that used early interim fluorodeoxyglucose posit...
S-EPMC4966513 | biostudies-literature
UnknownA Multicenter Feasibility Study of a Novel Curriculum for Oncology Trainees Regarding Medical Cannabis.

Background

Oncology providers often lack the confidence to make clinical recommendations about medical cannabis (MC). This study aimed to develop and evaluate the feasibility of implementing an educational curriculum on the use of MC in patient care for oncology trainees.

Methods

A mu...
S-EPMC12934205 | biostudies-literature
UnknownBrentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.

Background

Brentuximab vedotin is an anti-CD30 antibody-drug conjugate that has been approved for relapsed and refractory Hodgkin's lymphoma.

Methods

We conducted an open-label, multicenter, randomized phase 3 trial involving patients with previously untreated stage III or IV classic ...
S-EPMC5819601 | biostudies-literature
Sort   by:  
 Page size